Histamine and Histaminergic Receptors in Colorectal Cancer: From Basic Science to Evidence-based Medicine

E-ISSN： 1875-5992|18|1|15-20

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.18, Iss.1, 2018-03, pp. : 15-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An evidence-based estimate of the appropriate radiotherapy utilization rate for colorectal cancer

By Foroudi F. Tyldesley S. Barbera L. Huang J. Mackillop W.J.

International Journal of Radiation Oncology*Biology*Physics, Vol. 56, Iss. 5, 2003-08 ,pp. : 1295-1307

Elsevier

Access to resources Recommend Favorite

Surveys, Quality Cancer Care, and Evidence-Based Medicine: Embracing Care Delivery Drivers

By Wagman Lawrence

Annals of Surgical Oncology, Vol. 15, Iss. 12, 2008-12 ,pp. : 3333-3334

Springer Publishing Company

Access to resources Recommend Favorite

Mechanistic versus Empirical Explanations and Evidence-based Medicine

By Maclure Malcolm

Acta Oncologica, Vol. 37, Iss. 1, 1998-05 ,pp. : 11-12

Informa Healthcare

Access to resources Recommend Favorite

The -149C>T polymorphism of DNMT3B is not associated with colorectal cancer risk: Evidence from a meta-analysis based on case-control studies

Experimental and Therapeutic Medicine, Vol. 4, Iss. 4, 2012-01 ,pp. : 728-732

Spandidos Publications

Access to resources Recommend Favorite

Report from a symposium on dissemination of evidence-based cancer prevention programs (United States)

By Kim D.J.

Cancer Causes and Control, Vol. 14, Iss. 4, 2003-05 ,pp. : 399-401

Springer Publishing Company

Access to resources Recommend Favorite